BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10462060)

  • 1. Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors.
    Pertwee RG
    Life Sci; 1999; 65(6-7):597-605. PubMed ID: 10462060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of cannabinoid receptor ligands.
    Pertwee RG
    Curr Med Chem; 1999 Aug; 6(8):635-64. PubMed ID: 10469884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat.
    Price TJ; Helesic G; Parghi D; Hargreaves KM; Flores CM
    Neuroscience; 2003; 120(1):155-62. PubMed ID: 12849749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CB1 cannabinoid receptor-mediated neurite remodeling in mouse neuroblastoma N1E-115 cells.
    Zhou D; Song ZH
    J Neurosci Res; 2001 Aug; 65(4):346-53. PubMed ID: 11494371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of cannabinoid CB1 and CB2 receptors.
    Pertwee RG
    Pharmacol Ther; 1997; 74(2):129-80. PubMed ID: 9336020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals.
    Griffin G; Fernando SR; Ross RA; McKay NG; Ashford ML; Shire D; Huffman JW; Yu S; Lainton JA; Pertwee RG
    Eur J Pharmacol; 1997 Nov; 339(1):53-61. PubMed ID: 9450616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR; Egertová M
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
    Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.
    Galiègue S; Mary S; Marchand J; Dussossoy D; Carrière D; Carayon P; Bouaboula M; Shire D; Le Fur G; Casellas P
    Eur J Biochem; 1995 Aug; 232(1):54-61. PubMed ID: 7556170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical demonstration of CB1 cannabinoid receptors in the anterior lobe of the pituitary gland.
    Wenger T; Fernández-Ruiz JJ; Ramos JA
    J Neuroendocrinol; 1999 Nov; 11(11):873-8. PubMed ID: 10520138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CB2 cannabinoid receptor mRNA in adult rat retina.
    Lu Q; Straiker A; Lu Q; Maguire G
    Vis Neurosci; 2000; 17(1):91-5. PubMed ID: 10750830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons.
    Skaper SD; Buriani A; Dal Toso R; Petrelli L; Romanello S; Facci L; Leon A
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3984-9. PubMed ID: 8633002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid receptors undergo axonal flow in sensory nerves.
    Hohmann AG; Herkenham M
    Neuroscience; 1999; 92(4):1171-5. PubMed ID: 10426476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
    Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
    FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
    Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC
    Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of the neural cannabinoid receptor in rat brain.
    Pettit DA; Harrison MP; Olson JM; Spencer RF; Cabral GA
    J Neurosci Res; 1998 Feb; 51(3):391-402. PubMed ID: 9486774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
    Romero TR; Resende LC; Guzzo LS; Duarte ID
    Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology of cannabinoid receptors and their ligands: an overview.
    Pertwee RG
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.